bupropion associated_with withdrawal
Evidence from:
primary |
all sources
Evidence (1 sources)
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
At target quit data (TQD), the bupropion group had higher mean withdrawal symptoms (32.3) compared with the placebo group (30.7) (P = 0.04).
confidence: 0.90